Evidence Hub

Phenotype Spectrum in VRK1 Pathogenic Variants

Malek EG, Biliciler S, Sheikh K

Journal of clinical neuromuscular disease, 2026

1 citation

Abstract

Abstract: Vaccinia-Related-Kinase-1 (VRK1) gene pathogenic variants have been identified in patients presenting with a slowly progressive symmetric distal weakness with electrophysiologic findings predominantly suggestive of pure motor axonal neuropathy/neuronopathy. VRK1-related presentations exhibit a considerable phenotypic heterogeneity with a proportion of patients presenting with features suggestive of multisystem involvement. Notably, the severity of the phenotype might have a correlation with the earlier age of onset. We present a case of a 33-year-old patient with a VRK1 pathogenic variant with clinical and electrophysiologic findings of distal symmetric motor involvement along with sensory manifestation, bilateral cataracts, and cryptorchism. A brief literature review of phenotypic spectrum associated with pathogenic variants in VRK1 gene is also presented.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free